CoChat
Sign Up
Cited by 317Hemoglobin structure and functionHemoglobinopathies and Related DisordersProtein Interaction Studies and Fluorescence Analysis

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Hemoglobin: Structure, Function and Allostery

Open access
Ahmed, Mostafa H., Ghatge, Mohini S., Safo, Martin K.·2020·Subcellular Biochemistry
DOI 10.1007/978-3-030-41769-7_14PMC PMC7370311
Open this paper in CoChat — free account

Abstract

This chapter reviews how allosteric (heterotrophic) effectors and natural mutations impact hemoglobin (Hb) primary physiological function of oxygen binding and transport. First, an introduction about the structure of Hb is provided, including the ensemble of tense and relaxed Hb states and the dynamic equilibrium of Hb multistate. This is followed by a brief review of Hb variants with altered Hb structure and oxygen binding properties. Finally, a review of different endogenous and exogenous allosteric effectors of Hb is presented with particular emphasis on the atomic interactions of synthetic ligands with altered allosteric function of Hb that could potentially be harnessed for the treatment of diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-3-030-41769-7_14

Cites

0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 195

  1. Abdulmalik O, Safo MK, Lerner NB et al (2004) Characterization of hemoglobin bassett (alpha94Asp → Ala), a variant with very low oxygen affinity. Am J Hematol 77:268–276. https://doi.org/10.1002/ajh.20184 · DOI
  2. Abdulmalik O, Safo MK, Chen Q et al (2005) 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells. Br J Haematol 128:552–561. https://doi.org/10.1111/j.1365-2141.2004.05332.x · DOI
  3. Abdulmalik O, Ghatge MS, Musayev FN et al (2011) Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin Corrigendum. Acta Crystallogr D Biol Crystallogr 67:1076. https://doi.org/10.1107/S0907444911045860 · DOI
  4. Abraham DJ, Mehanna AS, Williams FL (1982) Design, synthesis, and testing of potential antisickling agents. 1. halogenated benzyloxy and phenoxy acids. J Med Chem 25:1015–1017. https://doi.org/10.1021/jm00351a002 · DOI
  5. Abraham DJ, Perutz MF, Phillips SE (1983a) Physiological and x-ray studies of potential antisickling agents. Proc Natl Acad Sci USA 80:324–328. https://doi.org/10.1073/pnas.80.2.324 · DOI
  6. Abraham DJ, Perutz MF, Phillips SE (1983b) Physiological and x-ray studies of potential antisickling agents. PNAS 80:324–328. https://doi.org/10.1073/pnas.80.2.324 · DOI
  7. Abraham DJ, Kennedy PE, Mehanna AS et al (1984) Design, synthesis, and testing of potential antisickling agents. 4. structure-activity relationships of benzyloxy and phenoxy acids. J Med Chem 27:967–978. https://doi.org/10.1021/jm00374a006 · DOI
  8. Abraham DJ, Mehanna AS, Wireko FC et al (1991) Vanillin, a potential agent for the treatment of sickle cell anemia. Blood 77:1334–1341 · DOI
  9. Abraham DJ, Peascoe RA, Randad RS, Panikker J (1992a) X-ray diffraction study of di and tetra-ligated T-state hemoglobin from high salt crystals. J Mol Biol 227:480–492. https://doi.org/10.1016/0022-2836(92)90902-V · DOI
  10. Abraham DJ, Wireko FC, Randad RS et al (1992b) Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31:9141–9149. https://doi.org/10.1021/bi00153a005 · DOI
  11. Abraham DJ, Safo MK, Boyiri T et al (1995) How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium. Biochemistry 34:15006–15020. https://doi.org/10.1021/bi00046a007 · DOI
  12. Akinsheye I, Klings ES (2010) Sickle cell anemia and vascular dysfunction: the nitric oxide connection. J Cell Physiol 224:620–625. https://doi.org/10.1002/jcp.22195 · DOI
  13. Aliyu ZY, Gordeuk V, Sachdev V et al (2008) Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol 83:485–490. https://doi.org/10.1002/ajh.21162 · DOI
  14. Arnone A (1972) X-ray diffraction study of binding of 2,3-diphosphoglycerate to human deoxyhaemoglobin. Nature 237:146–149. https://doi.org/10.1038/237146a0 · DOI
  15. Arous N, Braconnier F, Thillet J et al (1981) Hemoglobin Saint Mandé beta 102 (G4) asn replaced by tyr: a new low oxygen affinity variant. FEBS Lett 126:114–116. https://doi.org/10.1016/0014-5793(81)81046-0 · DOI
  16. Baldwin J, Chothia C (1979) Haemoglobin: The structural changes related to ligand binding and its allosteric mechanism. J Mol Biol 129:175–220. https://doi.org/10.1016/0022-2836(79)90277-8 · DOI
  17. Barrick D, Ho NT, Simplaceanu V et al (1997) A test of the role of the proximal histidines in the Perutz model for cooperativity in haemoglobin. Nat Struct Biol 4:78–83 · DOI
  18. Beddell CR, Goodford PJ, Kneen G et al (1984) Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes. Br J Pharmacol 82:397–407. https://doi.org/10.1111/j.1476-5381.1984.tb10775.x · DOI
  19. Belcher JD, Bryant CJ, Nguyen J et al (2003) Transgenic sickle mice have vascular inflammation. Blood 101:3953–3959. https://doi.org/10.1182/blood-2002-10-3313 · DOI
  20. Benesch R, Benesch RE (1967) The effect of organic phosphates from the human erythrocyte on the allosteric properties of hemoglobin. Biochem Biophys Res Commun 26:162–167. https://doi.org/10.1016/0006-291X(67)90228-8 · DOI
  21. Benesch RE, Kwong S, Edalji R, Benesch R (1979) Alpha chain mutations with opposite effects on the gelation of hemoglobin S. J Biol Chem 254:8169–8172 · DOI
  22. Berenbrink M (2006) Evolution of vertebrate haemoglobins: Histidine side chains, specific buffer value and Bohr effect. Respir Physiol Neurobiol 154:165–184. https://doi.org/10.1016/j.resp.2006.01.002 · DOI
  23. Bettati S, Mozzarelli A (1997) T state hemoglobin binds oxygen noncooperatively with allosteric effects of protons, inositol hexaphosphate, and chloride. J Biol Chem 272:32050–32055. https://doi.org/10.1074/jbc.272.51.32050 · DOI
  24. Bettati S, Mozzarelli A, Perutz MF (1998) Allosteric mechanism of haemoglobin: rupture of salt-bridges raises the oxygen affinity of the T-structure. J Mol Biol 281:581–585. https://doi.org/10.1006/jmbi.1998.1983 · DOI
  25. Biolo A, Greferath R, Siwik DA et al (2009) Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate. PNAS 106:1926–1929. https://doi.org/10.1073/pnas.0812381106 · DOI
  26. Birukou I, Soman J, Olson JS (2011) Blocking the gate to ligand entry in human hemoglobin. J Biol Chem 286:10515–10529. https://doi.org/10.1074/jbc.M110.176271 · DOI
  27. Bissé E, Schaeffer-Reiss C, Van Dorsselaer A et al (2017) Hemoglobin Kirklareli (α H58L), a new variant associated with iron deficiency and increased CO binding. J Biol Chem 292:2542–2555. https://doi.org/10.1074/jbc.M116.764274 · DOI
  28. Bohr C, Hasselbalch K, Krogh A (1904) Ueber einen in biologischer Beziehung wichtigen Einfluss, den die Kohlensäurespannung des Blutes auf dessen Sauerstoffbindung übt1. Skandinavisches Archiv Für Physiologie 16:402–412. https://doi.org/10.1111/j.1748-1716.1904.tb01382.x · DOI
  29. Bonaventura J, Riggs A (1968) Hemoglobin Kansas, a human hemoglobin with a neutral amino acid substitution and an abnormal oxygen equilibrium. J Biol Chem 243:980–991 · DOI
  30. Bonaventura C, Arumugam M, Cashon R et al (1994) Chloride masks effects of opposing positive charges in Hb A and Hb Hinsdale (β139 Asn → Lys) that can modulate cooperativity as well as oxygen affinity. J Mol Biol 239:561–568. https://doi.org/10.1006/jmbi.1994.1395 · DOI
  31. Borg I, Valentino M, Fiorini A, Felice AE (1997) Hb Setif [alpha 94(G1)Asp → Tyr] in Malta. Hemoglobin 21:91–96 · DOI
  32. Botha MC, Beale D, Isaacs WA, Lehmann H (1966) Hemoglobin J Cape Town-alpha-2 92 arginine replaced by glutamine beta-2. Nature 212:792–795. https://doi.org/10.1038/212792a0 · DOI
  33. Boyiri T, Safo MK, Danso-Danquah RE et al (1995) Bisaldehyde allosteric effectors as molecular ratchets and probes. Biochemistry 34:15021–15036. https://doi.org/10.1021/bi00046a008 · DOI
  34. Brunori M, Coletta M, Di Cera E (1986) A cooperative model for ligand binding to biological macromolecules as applied to oxygen carriers. Biophys Chem 23:215–222. https://doi.org/10.1016/0301-4622(86)85006-2 · DOI
  35. Bunn HF, Bradley TB, Davis WE et al (1972) Structural and functional studies on hemoglobin Bethesda (alpha2beta2 145His), a varient associated with compensatory erythrocytosis. J Clin Invest 51:2299–2309. https://doi.org/10.1172/JCI107040 · DOI
  36. Busch MR, Ho C (1990) Effects of anions on the molecular basis of the Bohr effect of hemoglobin. Biophys Chem 37:313–322. https://doi.org/10.1016/0301-4622(90)88031-M · DOI
  37. Carrell RW, Lehmann H, Hutchison HE (1966) Haemoglobin Köln (beta-98 valine–methionine): an unstable protein causing inclusion-body anaemia. Nature 210:915–916. https://doi.org/10.1038/210915a0 · DOI
  38. Charache S, Weatherall DJ, Clegg JB (1966) Polycythemia associated with a hemoglobinopathy. J Clin Invest 45:813–822. https://doi.org/10.1172/JCI105397 · DOI
  39. Chen Q, Lalezari I, Nagel RL, Hirsch RE (2005) Liganded hemoglobin structural perturbations by the allosteric effector L35. Biophys J 88:2057–2067. https://doi.org/10.1529/biophysj.104.046136 · DOI
  40. Como PF, Wylie BR, Trent RJ et al (1991) A new unstable and low oxygen affinity hemoglobin variant: Hb Stanmore [beta 111(G13)Val–Ala]. Hemoglobin 15:53–65 · DOI
  41. Connor J, Pak CC, Schroit AJ (1994) Exposure of phosphatidylserine in the outer leaflet of human red blood cells. relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 269:2399–2404 · DOI
  42. Czerminski R, Elber R (1991) Computational studies of ligand diffusion in globins: I. Leghemoglobin. Proteins: Struct Funct Bioinform 10:70–80. https://doi.org/10.1002/prot.340100107 · DOI
  43. Dacie JV, Shinton NK, Gaffney PJ, Lehmann H (1967) Haemoglobin Hammersmith (beta-42 (CDI) Phe replaced by ser). Nature 216:663–665. https://doi.org/10.1038/216663a0 · DOI
  44. De Franceschi L (2009) Pathophisiology of sickle cell disease and new drugs for the treatment. Mediterr J Hematol Infect Dis 1:e2009024. https://doi.org/10.4084/MJHID.2009.024 · DOI
  45. Deshpande TM, Pagare PP, Ghatge MS et al (2018) Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation. Acta Crystallogr D Struct Biol 74:956–964. https://doi.org/10.1107/S2059798318009919 · DOI
  46. Dinçol G, Dinçol K, Erdem S et al (1994) Hb Capa or alpha (2)94(G1)Asp → Gly beta 2, a mildly unstable variant with an A → G (GAC → GGC) mutation in codon 94 of the alpha 1-globin gene. Hemoglobin 18:57–60 · DOI
  47. Doyle ML, Lew G, Turner GJ et al (1992) Regulation of oxygen affinity by quaternary enhancement: does hemoglobin ypsilanti represent an allosteric intermediate? Proteins: Struct Funct Bioinform 14:351–362. https://doi.org/10.1002/prot.340140304 · DOI
  48. Eaton WA, Hofrichter J (1990) Sickle cell hemoglobin polymerization. Adv Protein Chem 40:63–279 · DOI
  49. Efremov GD, Stojmirovic E, Lam HL et al (1978) HB Beth Israel (beta 102 [G4] Asn replaced by Ser) observed in a Yugoslavian teenager. Hemoglobin 2:75–77. https://doi.org/10.3109/03630267808999192 · DOI
  50. Elber R (2010) Ligand diffusion in globins: simulations versus experiment. Curr Opin Struct Biol 20:162–167. https://doi.org/10.1016/j.sbi.2010.01.002 · DOI
  51. Fan J-S, Zheng Y, Choy W-Y et al (2013) Solution structure and dynamics of human hemoglobin in the carbonmonoxy form. Biochemistry 52:5809–5820. https://doi.org/10.1021/bi4005683 · DOI
  52. Fermi G (1975) Three-dimensional fourier synthesis of human deoxyhaemoglobin at 2–5 a resolution: refinement of the atomic model. J Mol Biol 97:237–256. https://doi.org/10.1016/s0022-2836(75)80037-4 · DOI
  53. Fernandez EJ, Abad-Zapatero C, Olsen KW (2000) Crystal structure of Lysβ182-Lysβ282 crosslinked hemoglobin: A possible allosteric intermediate 11 Edited by K. Nagai. J Mol Biol 296:1245–1256. https://doi.org/10.1006/jmbi.2000.3525 · DOI
  54. Fronticelli C, Pechik I, Brinigar WS et al (1994) Chloride ion independence of the Bohr effect in a mutant human hemoglobin beta (V1M + H2deleted). J Biol Chem 269:23965–23969 · DOI
  55. Gell DA (2018) Structure and function of haemoglobins. Blood Cells Mol Dis 70:13–42. https://doi.org/10.1016/j.bcmd.2017.10.006 · DOI
  56. Ghatge MS, Ahmed MH, Omar ASM et al (2016) Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation. J Struct Biol 194:446–450. https://doi.org/10.1016/j.jsb.2016.04.003 · DOI
  57. Goldstein SR, Liu C, Safo MK et al (2018) Design, synthesis, and biological evaluation of allosteric effectors that enhance CO release from carboxyhemoglobin. ACS Med Chem Lett 9:714–718. https://doi.org/10.1021/acsmedchemlett.8b00166 · DOI
  58. Gong Q, Simplaceanu V, Lukin JA et al (2006) Quaternary structure of carbonmonoxyhemoglobins in solution: structural changes induced by the allosteric effector inositol hexaphosphate. Biochemistry 45:5140–5148. https://doi.org/10.1021/bi052424h · DOI
  59. Grasso JA, Sullivan AL, Sullivan LW (1975) Ultrastructural studies of the bone marrow in sickle cell anaemia. II. the morphology of erythropoietic cells and their response to deoxygenation in vitro. Br J Haematol 31:381–389. https://doi.org/10.1111/j.1365-2141.1975.tb00869.x · DOI
  60. Gupta RK, Benovic JL, Rose ZB (1979) Location of the allosteric site for 2,3-bisphosphoglycerate on human oxy- and deoxyhemoglobin as observed by magnetic resonance spectroscopy. J Biol Chem 254:8250–8255 · DOI
  61. Hänel P, Andréani P, Gräler MH (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21:1202–1209. https://doi.org/10.1096/fj.06-7433com · DOI
  62. Hardison R, Chao KM, Schwartz S et al (1994) Globin gene server: a prototype E-mail database server featuring extensive multiple alignments and data compilation for electronic genetic analysis. Genomics 21:344–353. https://doi.org/10.1006/geno.1994.1275 · DOI
  63. Hardison RC, Chui DH, Riemer C et al (2001) Databases of human hemoglobin variants and other resources at the globin gene server. Hemoglobin 25:183–193 · DOI
  64. Harrington DJ, Adachi K, Royer WE (1997) The high resolution crystal structure of deoxyhemoglobin S. J Mol Biol 272:398–407. https://doi.org/10.1006/jmbi.1997.1253 · DOI
  65. He Z, Russell JE (2004a) Effect of zeta-globin substitution on the O2-transport properties of Hb S in vitro and in vivo. Biochem Biophys Res Commun 325:1376–1382. https://doi.org/10.1016/j.bbrc.2004.10.180 · DOI
  66. He Z, Russell JE (2004b) Antisickling effects of an endogenous human alpha-like globin. Nat Med 10:365–367. https://doi.org/10.1038/nm1022 · DOI
  67. Henry ER, Bettati S, Hofrichter J, Eaton WA (2002) A tertiary two-state allosteric model for hemoglobin. Biophys Chem 98:149–164. https://doi.org/10.1016/S0301-4622(02)00091-1 · DOI
  68. Huisman THJ, Carver MFH, Efremov G (1996) A syllabus of human hemoglobin variants. The Sickle Cell Anemia Foundation, Augusta, GA, USA
  69. Ito K, Anada Y, Tani M et al (2007) Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem Biophys Res Commun 357:212–217. https://doi.org/10.1016/j.bbrc.2007.03.123 · DOI
  70. Janin J, Wodak SJ (1993) The quaternary structure of carbonmonoxy hemoglobin ypsilanti. Proteins: Struct Funct Bioinform 15:1–4. https://doi.org/10.1002/prot.340150102 · DOI
  71. Jayaraman V, Rodgers KR, Mukerji I, Spiro TG (1995) Hemoglobin allostery: resonance Raman spectroscopy of kinetic intermediates. Science 269:1843–1848. https://doi.org/10.1126/science.7569921 · DOI
  72. Jenkins JD, Musayev FN, Danso-Danquah R et al (2009) Structure of relaxed-state human hemoglobin: insight into ligand uptake, transport and release. Acta Cryst D 65:41–48. https://doi.org/10.1107/S0907444908037256 · DOI
  73. Jensen M, Oski FA, Nathan DG, Bunn HF (1975) Hemoglobin Syracuse (alpha2beta2-143(H21)His leads to Pro), a new high-affinity variant detected by special electrophoretic methods. observations on the auto-oxidation of normal and variant hemoglobins. J Clin Invest 55:469–477. https://doi.org/10.1172/JCI107953 · DOI
  74. Jones RT, Osgood EE, Brimhall B, Koler RD (1967) Hemoglobin Yakina. I. clinical and biochemical studies. J Clin Invest 46:1840–1847. https://doi.org/10.1172/JCI105674 · DOI
  75. Jorge SE, Bringas M, Petruk AA et al (2018) Understanding the molecular basis of the high oxygen affinity variant human hemoglobin Coimbra. Arch Biochem Biophys 637:73–78. https://doi.org/10.1016/j.abb.2017.11.010 · DOI
  76. Kamel K, el-Najjar A, Webber BB et al (1985) Hb Doha or alpha 2 beta 2[X-N-Met-1(NA1)Val–Glu]; a new beta-chain abnormal hemoglobin observed in a Qatari female. Biochim Biophys Acta 831:257–260. https://doi.org/10.1016/0167-4838(85)90043-3 · DOI
  77. Kato GJ, Lawrence MP, Mendelsohn LG et al (2013) Phase 1 clinical trial of the candidate anti-sickling agent Aes-103 In adults with sickle cell anemia. Blood 122:1009–1009 · DOI
  78. Kavanaugh JS, Rogers PH, Case DA, Arnone A (1992) High-resolution x-ray study of deoxyhemoglobin Rothschild 37.beta. Trp.fwdarw. Arg: a mutation that creates an intersubunit chloride-binding site. Biochemistry 31:4111–4121. https://doi.org/10.1021/bi00131a030 · DOI
  79. Kavanaugh JS, Weydert JA, Rogers PH et al (2001) Site-directed mutations of human hemoglobin at residue 35beta: a residue at the intersection of the alpha1beta1, alpha1beta2, and alpha1alpha2 interfaces. Protein Sci 10:1847–1855. https://doi.org/10.1110/ps.16401 · DOI
  80. Kavanaugh JS, Rogers PH, Arnone A (2005) Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions. Biochemistry 44:6101–6121. https://doi.org/10.1021/bi047813a · DOI
  81. Khandelwal SR, Randad RS, Lin PS et al (1993) Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J Physiol 265:H1450–H1453. https://doi.org/10.1152/ajpheart.1993.265.4.H1450 · DOI
  82. Kilmartin JV, Imai K, Jones RT et al (1978) Role of Bohr group salt bridges in cooperativity in hemoglobin. Biochim Biophys Acta 534:15–25. https://doi.org/10.1016/0005-2795(78)90471-3 · DOI
  83. King MA, Wiltshire BG, Lehmann H, Morimoto H (1972) An unstable haemoglobin with reduced oxygen affinity: haemoglobin Peterborough, 3 (GI3) Valine lead to Phenylalanine, its interaction with normal haemoglobin and with haemoglobin Lepore. Br J Haematol 22:125–134. https://doi.org/10.1111/j.1365-2141.1972.tb08794.x · DOI
  84. Kister J, Kiger L, Francina A et al (1995) Hemoglobin Roanne [alpha 94(G1) Asp → Glu]: a variant of the alpha 1 beta 2 interface with an unexpected high oxygen affinity. Biochim Biophys Acta 1246:34–38. https://doi.org/10.1016/0167-4838(94)00190-r · DOI
  85. Kleinberg L, Grossman SA, Piantadosi S et al (1999) Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme. J Clin Oncol 17:2593–2603. https://doi.org/10.1200/JCO.1999.17.8.2593 · DOI
  86. Koshland DE, Némethy G, Filmer D (1966) Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 5:365–385. https://doi.org/10.1021/bi00865a047 · DOI
  87. Kosmachevskaya OV, Topunov AF (2018) Alternate and additional functions of erythrocyte hemoglobin. Biochem Mosc 83:1575–1593. https://doi.org/10.1134/S0006297918120155 · DOI
  88. Laberge M, Kövesi I, Yonetani T, Fidy J (2005) R-state hemoglobin bound to heterotropic effectors: models of the DPG, IHP and RSR13 binding sites. FEBS Lett 579:627–632. https://doi.org/10.1016/j.febslet.2004.12.033 · DOI
  89. Ladner RC, Heidner EJ, Perutz MF (1977) The structure of horse methaemoglobin at 2-0 A resolution. J Mol Biol 114:385–414. https://doi.org/10.1016/0022-2836(77)90256-x · DOI
  90. Lalezari I, Rahbar S, Lalezari P et al (1988) LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein. PNAS 85:6117–6121. https://doi.org/10.1073/pnas.85.16.6117 · DOI
  91. Lalezari I, Lalezari P, Poyart C et al (1990) New effectors of human hemoglobin: structure and function. Biochemistry 29:1515–1523. https://doi.org/10.1021/bi00458a024 · DOI
  92. Lokich JJ, Moloney WC, Bunn HF et al (1973) Hemoglobin brigham (alpha2Abeta2100 Pro–Leu). Hemoglobin variant associated with familial erythrocytosis. J Clin Invest 52:2060–2067. https://doi.org/10.1172/JCI107390 · DOI
  93. Lukin JA, Ho C (2004) The structure–function relationship of hemoglobin in solution at atomic resolution. Chem Rev 104:1219–1230. https://doi.org/10.1021/cr940325w · DOI
  94. Lukin JA, Kontaxis G, Simplaceanu V et al (2003) Quaternary structure of hemoglobin in solution. PNAS 100:517–520. https://doi.org/10.1073/pnas.232715799 · DOI
  95. Lukin JA, Kontaxis G, Simplaceanu V et al (2004) Backbone resonance assignments of human adult hemoglobin in the carbonmonoxy form. J Biomol NMR 28:203–204. https://doi.org/10.1023/B:JNMR.0000013816.64039.6f · DOI
  96. Mairbäurl H, Weber RE (2012) Oxygen transport by hemoglobin. Compr Physiol 2:1463–1489. https://doi.org/10.1002/cphy.c080113 · DOI
  97. Makowski L, Bardhan J, Gore D et al (2011) WAXS studies of the structural diversity of hemoglobin in solution. J Mol Biol 408:909–921. https://doi.org/10.1016/j.jmb.2011.02.062 · DOI
  98. Marden MC, Bohn B, Kister J, Poyart C (1990) Effectors of hemoglobin. separation of allosteric and affinity factors. Biophys J 57:397–403. https://doi.org/10.1016/S0006-3495(90)82556-X · DOI
  99. Mehanna AS, Abraham DJ (1990) Comparison of crystal and solution hemoglobin binding of selected antigelling agents and allosteric modifiers. Biochemistry 29:3944–3952. https://doi.org/10.1021/bi00468a022 · DOI
  100. Monod J, Wyman J, Changeux JP (1965) On the nature of allosteric transitions: a plausible model. J Mol Biol 12:88–118. https://doi.org/10.1016/s0022-2836(65)80285-6 · DOI
  101. Mozzarelli A, Rivetti C, Rossi GL et al (1991) Crystals of haemoglobin with the T quaternary structure bind oxygen noncooperatively with no Bohr effect. Nature 351:416–419. https://doi.org/10.1038/351416a0 · DOI
  102. Mueser TC, Rogers PH, Arnone A (2000) Interface sliding as illustrated by the multiple quaternary structures of liganded hemoglobin. Biochemistry 39:15353–15364. https://doi.org/10.1021/bi0012944 · DOI
  103. Muirhead H, Perutz MF (1963) Structure of hæemoglobin: a three-dimensional Fourier synthesis of reduced human haemoglobin at 5.5 Å resolution. Nature 199:633–638. https://doi.org/10.1038/199633a0 · DOI
  104. Murari J, Smith LL, Wilson JB et al (1977) Some properties of hemoglobin Gun Hill. Hemoglobin 1:267–282 · DOI
  105. Nagel RL, Johnson J, Bookchin RM et al (1980) Beta-chain contact sites in the haemoglobin S polymer. Nature 283:832–834. https://doi.org/10.1038/283832a0 · DOI
  106. Nakagawa A, Lui FE, Wassaf D et al (2014) Identification of a small molecule that increases hemoglobin oxygen affinity and reduces SS erythrocyte sickling. ACS Chem Biol 9:2318–2325. https://doi.org/10.1021/cb500230b · DOI
  107. Nakagawa A, Ferrari M, Schleifer G et al (2018) A triazole disulfide compound increases the affinity of hemoglobin for oxygen and reduces the sickling of human sickle cells. Mol Pharm 15:1954–1963. https://doi.org/10.1021/acs.molpharmaceut.8b00108 · DOI
  108. Nienhuis AW (1987) Hemoglobin: Molecular, genetic and clinical aspects: By H. F. Bunn and B. G. Forget. Philadelphia: W. B. Saunders Company. (1986). 690 pp. $99.00. Cell 48:731. https://doi.org/10.1016/0092-8674(87)90069-9 · DOI
  109. Nnamani IN, Joshi GS, Danso-Danquah R et al (2008) Pyridyl derivatives of benzaldehyde as potential antisickling agents. Chem Biodivers 5:1762–1769. https://doi.org/10.1002/cbdv.200890165 · DOI
  110. Noble RW, Hui HL, Kwiatkowski LD et al (2001) Mutational effects at the subunit interfaces of human hemoglobin: evidence for a unique sensitivity of the T quaternary state to changes in the hinge region of the alpha 1 beta 2 interface. Biochemistry 40:12357–12368. https://doi.org/10.1021/bi010988p · DOI
  111. O’Donnell S, Mandaro R, Schuster TM, Arnone A (1979) X-ray diffraction and solution studies of specifically carbamylated human hemoglobin A. evidence for the location of a proton- and oxygen-linked chloride binding site at valine 1 alpha. J Biol Chem 254:12204–12208 · DOI
  112. Oksenberg D, Dufu K, Patel MP et al (2016) GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease. Br J Haematol 175:141–153. https://doi.org/10.1111/bjh.14214 · DOI
  113. Omar AM, Mahran MA, Ghatge MS et al (2015) Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents. Org Biomol Chem 13:6353–6370. https://doi.org/10.1039/c5ob00367a · DOI
  114. Omar AM, Mahran MA, Ghatge MS et al (2016) Aryloxyalkanoic acids as non-covalent modifiers of the allosteric properties of hemoglobin. Molecules 21. https://doi.org/10.3390/molecules21081057 · DOI
  115. Pagare PP, Ghatge MS, Musayev FN et al (2018) Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease. Bioorg Med Chem 26:2530–2538. https://doi.org/10.1016/j.bmc.2018.04.015 · DOI
  116. Pagel PS, Hettrick DA, Montgomery MW et al (1998) RSR13, a synthetic allosteric modifier of hemoglobin, enhances recovery of stunned myocardium in dogs. Adv Exp Med Biol 454:527–531. https://doi.org/10.1007/978-1-4615-4863-8_63 · DOI
  117. Paoli M, Liddington R, Tame J et al (1996) Crystal structure of T state haemoglobin with oxygen bound at all four haems. J Mol Biol 256:775–792. https://doi.org/10.1006/jmbi.1996.0124 · DOI
  118. Patwa DC, Abraham DJ, Hung TC (1987) Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids. Blood Cells 12:589–601
  119. Perrella M, Cera ED (1999) CO ligation intermediates and the mechanism of hemoglobin cooperativity. J Biol Chem 274:2605–2608. https://doi.org/10.1074/jbc.274.5.2605 · DOI
  120. Perutz MF (1972a) Stereochemical mechanism of cooperative effects in haemoglobin. Biochimie 54:587–588. https://doi.org/10.1016/s0300-9084(72)80142-1 · DOI
  121. Perutz MF (1972b) Nature of haem-haem interaction. Nature 237:495–499. https://doi.org/10.1038/237495a0 · DOI
  122. Perutz MF (1976) Structure and mechanism of haemoglobin. Br Med Bull 32:195–208. https://doi.org/10.1093/oxfordjournals.bmb.a071363 · DOI
  123. Perutz MF (1983) Species adaptation in a protein molecule. Mol Biol Evol 1:1–28. https://doi.org/10.1093/oxfordjournals.molbev.a040299 · DOI
  124. Perutz MF (1989) Myoglobin and haemoglobin: role of distal residues in reactions with haem ligands. Trends Biochem Sci 14:42–44. https://doi.org/10.1016/0968-0004(89)90039-X · DOI
  125. Perutz MF, Poyart C (1983) Bezafibrate lowers oxygen affinity of haemoglobin. The Lancet 322:881–882. https://doi.org/10.1016/S0140-6736(83)90870-X · DOI
  126. Perutz MF, Muirhead H, Cox JM, Goaman LC (1968) Three-dimensional Fourier synthesis of horse oxyhaemoglobin at 2.8 A resolution: the atomic model. Nature 219:131–139. https://doi.org/10.1038/219131a0 · DOI
  127. Perutz MF, Muirhead H, Mazzarella L et al (1969) Identification of residues responsible for the alkaline Bohr effect in haemoglobin. Nature 222:1240–1243. https://doi.org/10.1038/2221240a0 · DOI
  128. Perutz MF, Giulio Fermi, Abraham DJ et al (1986) Hemoglobin as a receptor of drugs and peptides: x-ray studies of the stereochemistry of binding. J Am Chem Soc 108:1064–1078. https://doi.org/10.1021/ja00265a036 · DOI
  129. Perutz MF, Fermi G, Poyart C et al (1993) A novel allosteric mechanism in haemoglobin: structure of bovine deoxyhaemoglobin, absence of specific chloride-binding sites and origin of the chloride-linked Bohr effect in bovine and human haemoglobin. J Mol Biol 233:536–545. https://doi.org/10.1006/jmbi.1993.1530 · DOI
  130. Perutz MF, Shih DT -b., Williamson D (1994) The chloride effect in human haemoglobin. a new kind of allosteric mechanism. J Mol Biol 239:555–560. https://doi.org/10.1006/jmbi.1994.1394 · DOI
  131. Perutz MF, Wilkinson AJ, Paoli M, Dodson GG (1998) The stereochemical mechanism of the cooperative effects in hemoglobin revisited. Annu Rev Biophys Biomol Struct 27:1–34. https://doi.org/10.1146/annurev.biophys.27.1.1 · DOI
  132. Phelps Grella M, Danso-Danquah R, Safo MK et al (2000) Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin. J Med Chem 43:4726–4737. https://doi.org/10.1021/jm000199q · DOI
  133. Plaseska D, Dimovski AJ, Wilson JB et al (1991) Hemoglobin Montreal: a new variant with an extended beta chain due to a deletion of Asp, Gly, Leu at positions 73, 74, and 75, and an insertion of Ala, Arg, Cys, Gln at the same location. Blood 77:178–181 · DOI
  134. Poillon WN, Kim BC, Welty EV, Walder JA (1986) The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S. Arch Biochem Biophys 249:301–305. https://doi.org/10.1016/0003-9861(86)90006-8 · DOI
  135. Randad RS, Mahran MA, Mehanna AS, Abraham DJ (1991) Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J Med Chem 34:752–757. https://doi.org/10.1021/jm00106a041 · DOI
  136. Reissmann KR, Ruth WE, Nomura T (1961) A human hemoglobin with lowered oxygen affinity and impaired heme-heme interactions. J Clin Invest 40:1826–1833. https://doi.org/10.1172/JCI104406 · DOI
  137. Rhoda MD, Martin J, Blouquit Y et al (1983) Sickle cell hemoglobin fiber formation strongly inhibited by the Stanleyville II mutation (alpha 78 Asn leads to Lys). Biochem Biophys Res Commun 111:8–13. https://doi.org/10.1016/s0006-291x(83)80109-0 · DOI
  138. Richard V, Dodson GG, Mauguen Y (1993) Human deoxyhaemoglobin-2,3-diphosphoglycerate complex low-salt structure at 2.5 A resolution. J Mol Biol 233:270–274. https://doi.org/10.1006/jmbi.1993.1505 · DOI
  139. Rieder RF, Oski FA, Clegg JB (1969) Hemoglobin Philly (beta 35 tyrosine phenylalanine): studies in the molecular pathology of hemoglobin. J Clin Invest 48:1627–1642. https://doi.org/10.1172/JCI106128 · DOI
  140. Riemer C, ElSherbini A, Stojanovic N et al (1998) A database of experimental results on globin gene expression. Genomics 53:325–337. https://doi.org/10.1006/geno.1998.5524 · DOI
  141. Safo MK, Abraham DJ (2005) The enigma of the liganded hemoglobin end state: a novel quaternary structure of human carbonmonoxy hemoglobin. Biochemistry 44:8347–8359. https://doi.org/10.1021/bi050412q · DOI
  142. Safo MK, Bruno S (2011) Allosteric effectors of hemoglobin: past, present and future. In: Chemistry and biochemistry of oxygen therapeutics. Wiley, Ltd., pp 285–300
  143. Safo MK, Moure CM, Burnett JC et al (2001) High–resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector. Protein Sci 10:951–957 · DOI
  144. Safo MK, Boyiri T, Burnett JC et al (2002a) X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites. Acta Crystallogr D Biol Crystallogr 58:634–644. https://doi.org/10.1107/s0907444902002627 · DOI
  145. Safo MK, Burnett JC, Musayev FN et al (2002b) Structure of human carbonmonoxyhemoglobin at 2.16 Å: a snapshot of the allosteric transition. Acta Crystallographica Section D 58:2031–2037. https://doi.org/10.1107/S0907444902015809 · DOI
  146. Safo MK, Abdulmalik O, Danso-Danquah R et al (2004) Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds. J Med Chem 47:4665–4676. https://doi.org/10.1021/jm0498001 · DOI
  147. Safo MK, Abdulmalik O, Lin HR et al (2005) Structures of R- and T-state hemoglobin Bassett: elucidating the structural basis for the low oxygen affinity of a mutant hemoglobin. Acta Crystallogr D Biol Crystallogr 61:156–162. https://doi.org/10.1107/S0907444904030501 · DOI
  148. Safo MK, Ahmed MH, Ghatge MS, Boyiri T (2011) Hemoglobin-ligand binding: understanding Hb function and allostery on atomic level. Biochim Biophys Acta 1814:797–809. https://doi.org/10.1016/j.bbapap.2011.02.013 · DOI
  149. Safo MK, Ko T-P, Abdulmalik O et al (2013) Structure of fully liganded Hb ζ2β2s trapped in a tense conformation. Acta Crystallogr D Biol Crystallogr 69:2061–2071. https://doi.org/10.1107/S0907444913019197 · DOI
  150. Safo MK, Ko T-P, Schreiter ER, Russell JE (2015) Structural basis for the antipolymer activity of Hb ζ2β2s trapped in a tense conformation. J Mol Struct 1099:99–107. https://doi.org/10.1016/j.molstruc.2015.06.047 · DOI
  151. Sahu SC, Simplaceanu V, Gong Q et al (2007) Insights into the solution structure of human deoxyhemoglobin in the absence and presence of an allosteric effector. Biochemistry 46:9973–9980. https://doi.org/10.1021/bi700935z · DOI
  152. Sakuragawa M, Ohba Y, Miyaji T et al (1984) A Japanese boy with hemolytic anemia due to an unstable hemoglobin (Hb Bristol). Nippon Ketsueki Gakkai Zasshi 47:896–902
  153. Samaja M, Rovida E, Niggeler M et al (1987) The dissociation of carbon monoxide from hemoglobin intermediate. J Biol Chem 262:4528–4533 · DOI
  154. Samuni U, Dantsker D, Juszczak LJ et al (2004) Spectroscopic and functional characterization of T state hemoglobin conformations encapsulated in silica gels. Biochemistry 43:13674–13682. https://doi.org/10.1021/bi048531d · DOI
  155. Sawicki CA, Gibson QH (1976) Quaternary conformational changes in human hemoglobin studied by laser photolysis of carboxyhemoglobin. J Biol Chem 251:1533–1542 · DOI
  156. Sawicki CA, Gibson QH (1978) The relation between carbon monoxide binding and the conformational change of hemoglobin. Biophys J 24:21–33. https://doi.org/10.1016/S0006-3495(78)85328-4 · DOI
  157. Schneider RG, Atkins RJ, Hosty TS et al (1975) Haemoglobin Titusville: alpha94 Asp replaced by Asn. a new haemoglobin with a lowered affinity for oxygen. Biochim Biophys Acta 400:365–373 · DOI
  158. Schoenborn BP (1976) Dichloromethane as an antisickling agent in sickle cell hemoglobin. Proc Natl Acad Sci USA 73:4195–4199. https://doi.org/10.1073/pnas.73.11.4195 · DOI
  159. Schumacher MA, Dixon MM, Kluger R et al (1995) Allosteric transition intermediates modelled by crosslinked haemoglobins. Nature 375:84–87. https://doi.org/10.1038/375084a0 · DOI
  160. Schumacher MA, Zheleznova EE, Poundstone KS et al (1997) Allosteric intermediates indicate R2 is the liganded hemoglobin end state. Proc Natl Acad Sci USA 94:7841–7844. https://doi.org/10.1073/pnas.94.15.7841 · DOI
  161. Sharma VS, Newton GL, Ranney HM et al (1980) Hemoglobin Rothschild (beta 37(C3)Trp replaced by Arg): a high/low affinity hemoglobin mutant. J Mol Biol 144:267–280. https://doi.org/10.1016/0022-2836(80)90090-x · DOI
  162. Shaw E, Scott C, Suh J et al (2003) RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the radiation therapy oncology group recursive partitioning analysis brain metastases database. J Clin Oncol 21:2364–2371. https://doi.org/10.1200/JCO.2003.08.116 · DOI
  163. Shibayama N, Saigo S (2001) Direct observation of two distinct affinity conformations in the T state human deoxyhemoglobin. FEBS Lett 492:50–53. https://doi.org/10.1016/s0014-5793(01)02225-6 · DOI
  164. Shibayama N, Miura S, Tame JRH et al (2002) Crystal structure of horse carbonmonoxyhemoglobin-bezafibrate complex at 1.55-A resolution. a novel allosteric binding site in R-state hemoglobin. J Biol Chem 277:38791–38796. https://doi.org/10.1074/jbc.M205461200 · DOI
  165. Silva MM, Rogers PH, Arnone A (1992) A third quaternary structure of human hemoglobin A at 1.7-A resolution. J Biol Chem 267:17248–17256 · DOI
  166. Smith FR, Simmons KC (1994) Cyanomet human hemoglobin crystallized under physiological conditions exhibits the Y quaternary structure. Proteins 18:295–300. https://doi.org/10.1002/prot.340180310 · DOI
  167. Smith FR, Lattman EE, Carter CW (1991) The mutation beta 99 Asp-Tyr stabilizes Y-a new, composite quaternary state of human hemoglobin. Proteins 10:81–91. https://doi.org/10.1002/prot.340100202 · DOI
  168. Song X, Simplaceanu V, Ho NT, Ho C (2008) Effector-induced structural fluctuation regulates the ligand affinity of an allosteric protein: binding of inositol hexaphosphate has distinct dynamic consequences for the T and R states of hemoglobin. Biochemistry 47:4907–4915. https://doi.org/10.1021/bi7023699 · DOI
  169. Spiegel S, Milstien S (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397–407. https://doi.org/10.1038/nrm1103 · DOI
  170. Srinivasan R, Rose GD (1994) The T-to-R transformation in hemoglobin: a reevaluation. PNAS 91:11113–11117. https://doi.org/10.1073/pnas.91.23.11113 · DOI
  171. Stern W, Mathews D, McKew J et al (2012) A phase 1, first-in-man, dose-response study of Aes-103 (5-HMF), an anti-sickling, allosteric modifier of hemoglobin oxygen affinity in healthy norman volunteers. Blood 120:3210–3210 · DOI
  172. Stucker O, Laurent D, Duvelleroy M et al (1985) Incorporation of inositol hexaphosphate in stored erythrocytes: effect on tissue oxygenation. Life Support Syst 3(Suppl 1):458–461
  173. Sun DP, Zou M, Ho NT, Ho C (1997) Contribution of surface histidyl residues in the alpha-chain to the Bohr effect of human normal adult hemoglobin: roles of global electrostatic effects. Biochemistry 36:6663–6673. https://doi.org/10.1021/bi963121d · DOI
  174. Sun K, D’Alessandro A, Ahmed MH et al (2017) Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic metabolic reprogramming in sickle cell disease. Sci Rep 7:15281. https://doi.org/10.1038/s41598-017-13667-8 · DOI
  175. Szabo A, Karplus M (1972) A mathematical model for structure-function relations in hemoglobin. J Mol Biol 72:163–197. https://doi.org/10.1016/0022-2836(72)90077-0 · DOI
  176. Torrance J, Jacobs P, Restrepo A et al (1970) Intraerythrocytic adaptation to anemia. N Engl J Med 283:165–169. https://doi.org/10.1056/NEJM197007232830402 · DOI
  177. Traylor TG, Deardurff LA, Coletta M et al (1983) Reactivity of ferrous heme proteins at low pH. J Biol Chem 258:12147–12148 · DOI
  178. Vasseur C, Blouquit Y, Kister J et al (1992) Hemoglobin Thionville. An alpha-chain variant with a substitution of a glutamate for valine at NA-1 and having an acetylated methionine NH2 terminus. J Biol Chem 267:12682–12691 · DOI
  179. Vichinsky E, Hoppe CC, Ataga KI et al (2019) A phase 3 randomized trial of Voxelotor in sickle cell disease. N Engl J Med 381:509–519. https://doi.org/10.1056/NEJMoa1903212 · DOI
  180. Wilson J, Phillips K, Luisi B (1996) The crystal structure of horse deoxyhaemoglobin trapped in the high-affinity (R) state. J Mol Biol 264:743–756. https://doi.org/10.1006/jmbi.1996.0674 · DOI
  181. Winslow RM, Charache S (1975) Hemoglobin Richmond. Subunit dissociation and oxygen equilibrium properties. J Biol Chem 250:6939–6942 · DOI
  182. Winter PM, Miller JN (1976) Carbon monoxide poisoning. JAMA 236:1502–1504. https://doi.org/10.1001/jama.1976.03270140054029 · DOI
  183. Wireko FC, Abraham DJ (1991) X-ray diffraction study of the binding of the antisickling agent 12C79 to human hemoglobin. Proc Natl Acad Sci USA 88:2209–2211. https://doi.org/10.1073/pnas.88.6.2209 · DOI
  184. Wireko FC, Kellogg GE, Abraham DJ (1991) Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. J Med Chem 34:758–767. https://doi.org/10.1021/jm00106a042 · DOI
  185. Woods JA, Storey CJ, Babcock EE, Malloy CR (1998) Right-shifting the oxyhemoglobin dissociation curve with RSR13: effects on high-energy phosphates and myocardial recovery after low-flow ischemia. J Cardiovasc Pharmacol 31:359–363. https://doi.org/10.1097/00005344-199803000-00005 · DOI
  186. Xu GG, Deshpande TM, Ghatge MS et al (2015) Design, synthesis, and investigation of novel nitric oxide (NO)-releasing prodrugs as drug candidates for the treatment of ischemic disorders: insights into NO-releasing prodrug biotransformation and hemoglobin-NO biochemistry. Biochemistry 54:7178–7192. https://doi.org/10.1021/acs.biochem.5b01074 · DOI
  187. Xu GG, Pagare PP, Ghatge MS et al (2017) Design, synthesis, and biological evaluation of ester and ether derivatives of antisickling agent 5-HMF for the treatment of sickle cell disease. Mol Pharm 14:3499–3511. https://doi.org/10.1021/acs.molpharmaceut.7b00553 · DOI
  188. Yokoyama T, Neya S, Tsuneshige A et al (2006) R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35. J Mol Biol 356:790–801. https://doi.org/10.1016/j.jmb.2005.12.018 · DOI
  189. Yonetani T, Kanaori K (2013) How does hemoglobin generate such diverse functionality of physiological relevance? Biochim Biophys Acta 1834:1873–1884. https://doi.org/10.1016/j.bbapap.2013.04.026 · DOI
  190. Yonetani T, Tsuneshige A (2003) The global allostery model of hemoglobin: an allosteric mechanism involving homotropic and heterotropic interactions. CR Biol 326:523–532. https://doi.org/10.1016/S1631-0691(03)00150-1 · DOI
  191. Yonetani T, Park S-I, Tsuneshige A et al (2002) Global allostery model of hemoglobin. Modulation of O(2) affinity, cooperativity, and Bohr effect by heterotropic allosteric effectors. J Biol Chem 277:34508–34520. https://doi.org/10.1074/jbc.M203135200 · DOI
  192. Youssef AM, Safo MK, Danso-Danquah R et al (2002) Synthesis and X-ray studies of chiral allosteric modifiers of hemoglobin. J Med Chem 45:1184–1195. https://doi.org/10.1021/jm010358l · DOI
  193. Zago MA, Bottura C (1983) Splenic function in sickle-cell diseases. Clin Sci 65:297–302. https://doi.org/10.1042/cs0650297 · DOI
  194. Zaugg RH, Walder JA, Klotz IM (1977) Schiff base adducts of hemoglobin. Modifications that inhibit erythrocyte sickling. J Biol Chem 252:8542–8548 · DOI
  195. Zhang Y, Berka V, Song A et al (2014) Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression. J Clin Invest 124:2750–2761. https://doi.org/10.1172/JCI74604 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ahmed, M. H., Ghatge, M. S., & Safo, M. K.
Affiliations
Virginia Commonwealth University (US)
Corresponding author
Safo, Martin K.
ORCID
Venue
Subcellular Biochemistry
Publisher
Springer International Publishing
Published
2020
Volume
94
Pages
345-382
ISSN
  • 0306-0225 (ISSN-L)
  • 2542-8810
DOI
10.1007/978-3-030-41769-7_14
PMC
PMC7370311
OpenAlex
W3011621712
Cited by
317
References
202
Citations by year
2026: 65 · 2025: 72 · 2024: 63 · 2023: 60 · 2022: 34 · 2021: 21 · 2020: 2
FWCI
48.58
Type
book chapter
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Sub-cellular biochemistry/Subcellular biochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1s10od021756-01a1)
  • National Institute on Minority Health and Health Disparities (R01MD009124)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
Keywords
hemoglobin, allosteric regulation, oxygen binding, oxygen transport, hemoglobin variants, natural mutation, synthetic ligands, hemoglobin structure
MeSH terms
Allosteric Regulation, Hematologic Diseases, Hemoglobins, Humans, Ligands, Oxygen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review